Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Cost-Effectiveness Evaluation of the IBD-BOOST Digital Self-Management Intervention for Pain, Fatigue, and Faecal Incontinence in Patients with Inflammatory Bowel Disease: Results from a Randomised Controlled Trial

  • By

  • Chris Roukas

  • Laura Miller

  • Fionn Cléirigh Büttner

  • Thomas Hamborg

  • Vladimir Sergeevich Gordeev

  • Vari Wileman

  • Richard C G Pollok

  • Sonia Saxena

  • Rona Moss-Morris

  • Ailsa Hart

  • James O Lindsay

  • Christine Norton

  • Borislava Mihaylova

  • July 1, 2026

Share

Original Source(s)

Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial

  • by Chris Roukas, Laura Miller, Fionn Cléirigh Büttner, Thomas Hamborg, Vladimir Sergeevich Gordeev, Vari Wileman, Richard C G Pollok, Sonia Saxena, Rona Moss-Morris, Ailsa Hart, James O Lindsay, Christine Norton, Borislava Mihaylova

  • July 1, 2026

Related Content

Association of serological markers with endoscopic mucosal healing and disease activity in patients with inflammatory bowel disease: a retrospective study

Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease

Editorial: Metabolite-induced metabolic reprogramming in the immune system